Clinical Trials Directory

Trials / Completed

CompletedNCT00010816

Herbal Treatment of Hepatitis C in Methadone Maintained Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Hepatitis C (HCV) is a chronic viral illness leading to progressive liver damage that has emerged as a major public health issue in the United States. While HCV affects all population groups, individuals with a history of intravenous drug use form the largest known risk group. Between 90 and 100 percent of long term intravenous drug use will eventually test positive for HCV, and there is substantial risk that even short term experimentation will result in infection. Studies suggest that HCV will be the major cause of cirrhosis and liver cancer in the next century. Currently, approved therapy includes recombinant interferons, which lead to sustained remission in a minority of patients. However, patients abusing other substances, including alcohol, are not eligible for interferon therapy. The need for investigation into other potential therapies is clear. Current practice patterns in the Far East include the use of traditional herbal remedies for symptomatic chronic viral hepatitis. This study is intended to examine the effect of commonly used herbal remedies for the treatment of symptomatic HCV.

Conditions

Interventions

TypeNameDescription
DRUGHerbal remedies

Timeline

Start date
1998-09-01
Completion
2003-06-01
First posted
2001-02-05
Last updated
2006-08-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00010816. Inclusion in this directory is not an endorsement.